We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+12.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$95.4B
AUM Growth
+$9.26B
(+11%)
Cap. Flow
-$707M
Cap. Flow
% of AUM
-0.74%
Top 10 Holdings %
Top 10 Hldgs %
25.21%
Holding
4,380
New
32
Increased
1,513
Reduced
2,146
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 ETF
IWB
|
+$99.9M |
| 2 |
Uber
UBER
|
+$71M |
| 3 |
Broadcom
AVGO
|
+$36.2M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$32.6M |
| 5 |
lululemon athletica
LULU
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$139M |
| 2 |
Apple
AAPL
|
+$72.7M |
| 3 |
VMW
VMware, Inc
VMW
|
+$47.1M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$42.3M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$35.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.73% |
| 2 | Financials | 13% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 11.32% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
XPEL
XPEL
$1.38B
| $3.27M | ﹤0.01% |
60,793
-615
| -1% | -$33K |
|
1652
Arcus Biosciences
RCUS
$3.64B
| $3.27M | ﹤0.01% |
171,338
+1,489
| +0.9% | +$23.8K |
|
1653
Shenandoah Telecom
SHEN
$746M
| $3.27M | ﹤0.01% |
151,216
-8,969
| -6% | -$201K |
|
1654
Harmony Biosciences
HRMY
$2.24B
| $3.25M | ﹤0.01% |
100,545
-1,836
| -2% | -$51.2K |
|
1655
SAP
SAP
$238B
| $3.25M | ﹤0.01% |
20,992
+606
| +3% | +$87.6K |
|
1656
Veracyte
VCYT
$3.8B
| $3.24M | ﹤0.01% |
117,932
-447
| -0.4% | -$10.8K |
|
|
HTLF
1657
DELISTED
Heartland Financial USA, Inc.
HTLF
| $3.23M | ﹤0.01% |
85,822
-1,052
| -1% | -$33.2K |
|
1658
Mercury Insurance
MCY
$6.07B
| $3.2M | ﹤0.01% |
85,774
-1,777
| -2% | -$61.6K |
|
1659
Marcus & Millichap
MMI
$1.19B
| $3.2M | ﹤0.01% |
73,211
+1,531
| +2% | +$50.8K |
|
|
TGH
1660
DELISTED
Textainer Group Holdings limited
TGH
| $3.17M | ﹤0.01% |
64,523
-5,511
| -8% | -$254K |
|
1661
Chefs' Warehouse
CHEF
$4.5B
| $3.17M | ﹤0.01% |
107,769
+2,477
| +2% | +$59.8K |
|
1662
United Natural Foods
UNFI
$2.85B
| $3.17M | ﹤0.01% |
195,198
+3,736
| +2% | +$56.8K |
|
1663
Insteel Industries
IIIN
$625M
| $3.16M | ﹤0.01% |
82,527
-1,317
| -2% | -$43.5K |
|
1664
Monro
MNRO
$398M
| $3.16M | ﹤0.01% |
107,535
-527
| -0.5% | -$14.8K |
|
1665
Quanex
NX
$1.01B
| $3.15M | ﹤0.01% |
103,126
-710
| -0.7% | -$20.9K |
|
1666
Schneider National
SNDR
$6.25B
| $3.15M | ﹤0.01% |
123,599
-1
| -0% | -$25 |
|
1667
Simulations Plus
SLP
$371M
| $3.14M | ﹤0.01% |
70,248
-548
| -0.8% | -$21.7K |
|
1668
Surgery Partners
SGRY
$2.03B
| $3.14M | ﹤0.01% |
98,244
+2,308
| +2% | +$67K |
|
1669
Enterprise Financial Services Corp
EFSC
$2.39B
| $3.14M | ﹤0.01% |
70,363
-180
| -0.3% | -$7.03K |
|
1670
International Seaways
INSW
$4.57B
| $3.14M | ﹤0.01% |
68,971
+603
| +0.9% | +$27.7K |
|
1671
Delek US
DK
$3.58B
| $3.14M | ﹤0.01% |
121,564
-6,681
| -5% | -$177K |
|
1672
Immunovant
IMVT
$8.25B
| $3.13M | ﹤0.01% |
74,359
-206
| -0.3% | -$7.58K |
|
1673
TPG
TPG
$7.86B
| $3.13M | ﹤0.01% |
72,519
+1,702
| +2% | +$57.5K |
|
1674
PagerDuty
PD
$902M
| $3.13M | ﹤0.01% |
135,217
-1,380
| -1% | -$29.9K |
|
|
BDN
1675
Brandywine Realty Trust
BDN
$554M
| $3.11M | ﹤0.01% |
575,475
-7,988
| -1% | -$35.1K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2023 Portfolio in Review
As of Q4 2023, RhumbLine Advisers held 4,380 positions worth $95.4B, up 11% from $86.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 2.3%. RhumbLine Advisers opened 32 new positions and exited 67, leaving the 4,380-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2023 buy was CRH: 83,048 shares worth $5.74M.
- RhumbLine Advisers added most to iShares Russell 1000 ETF in Q4 2023, an estimated $99.9M increase.
- RhumbLine Advisers's biggest Q4 2023 reduction was Apple, cutting an estimated $72.7M.
- RhumbLine Advisers fully exited Activision Blizzard in Q4 2023, selling an estimated $139M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $95.4B portfolio in Q4 2023.
- RhumbLine Advisers opened 32 new positions and closed 67 in Q4 2023.
- RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $95.4B.
Based on RhumbLine Advisers's 13F filing for Q4 2023, filed 8 Feb 2024.